Ginkgo Bioworks Holdings Stock Market Value
| DNA Stock | USD 6.46 0.19 2.86% |
| Symbol | Ginkgo |
Ginkgo Bioworks Holdings Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.54) | Revenue Per Share | Quarterly Revenue Growth 0.262 | Return On Assets | Return On Equity |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ginkgo Bioworks 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ginkgo Bioworks' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ginkgo Bioworks.
| 02/11/2025 |
| 03/13/2025 |
If you would invest 0.00 in Ginkgo Bioworks on February 11, 2025 and sell it all today you would earn a total of 0.00 from holding Ginkgo Bioworks Holdings or generate 0.0% return on investment in Ginkgo Bioworks over 30 days. Ginkgo Bioworks is related to or competes with Enveric Biosciences, and Elevation Oncology. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming More
Ginkgo Bioworks Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ginkgo Bioworks' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ginkgo Bioworks Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 36.96 | |||
| Value At Risk | (9.86) | |||
| Potential Upside | 13.55 |
Ginkgo Bioworks Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ginkgo Bioworks' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ginkgo Bioworks' standard deviation. In reality, there are many statistical measures that can use Ginkgo Bioworks historical prices to predict the future Ginkgo Bioworks' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | 0.7379 | |||
| Treynor Ratio | (0.17) |
Ginkgo Bioworks Holdings Backtested Returns
Ginkgo Bioworks Holdings holds Efficiency (Sharpe) Ratio of -0.0458, which attests that the entity had a -0.0458 % return per unit of risk over the last 3 months. Ginkgo Bioworks Holdings exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Ginkgo Bioworks' Risk Adjusted Performance of (0.04), market risk adjusted performance of (0.16), and Standard Deviation of 7.55 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.38, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ginkgo Bioworks will likely underperform. At this point, Ginkgo Bioworks Holdings has a negative expected return of -0.33%. Please make sure to check out Ginkgo Bioworks' skewness, and the relationship between the treynor ratio and daily balance of power , to decide if Ginkgo Bioworks Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.72 |
Good predictability
Ginkgo Bioworks Holdings has good predictability. Overlapping area represents the amount of predictability between Ginkgo Bioworks time series from 11th of February 2025 to 26th of February 2025 and 26th of February 2025 to 13th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ginkgo Bioworks Holdings price movement. The serial correlation of 0.72 indicates that around 72.0% of current Ginkgo Bioworks price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.53 |
Ginkgo Bioworks Holdings lagged returns against current returns
Autocorrelation, which is Ginkgo Bioworks stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ginkgo Bioworks' stock expected returns. We can calculate the autocorrelation of Ginkgo Bioworks returns to help us make a trade decision. For example, suppose you find that Ginkgo Bioworks has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ginkgo Bioworks regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ginkgo Bioworks stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ginkgo Bioworks stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ginkgo Bioworks stock over time.
Current vs Lagged Prices |
| Timeline |
Ginkgo Bioworks Lagged Returns
When evaluating Ginkgo Bioworks' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ginkgo Bioworks stock have on its future price. Ginkgo Bioworks autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ginkgo Bioworks autocorrelation shows the relationship between Ginkgo Bioworks stock current value and its past values and can show if there is a momentum factor associated with investing in Ginkgo Bioworks Holdings.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:Check out Ginkgo Bioworks Correlation, Ginkgo Bioworks Volatility and Ginkgo Bioworks Alpha and Beta module to complement your research on Ginkgo Bioworks. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Ginkgo Bioworks technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.